Several single nucleotide polymorphisms (SNPs) of IGF-1 have been observed in non-alcoholic fatty liver disease [27]. Abnormal IGF-1 activation and downstream signaling also contribute to various types of malignancies and treatment resistance [28,29]. The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatotic liver disease.